Dupérat V G, Fauchon M, Nurden A T, Vergnes C
CNRS UMR 5533, Hôpital Cardiologique, Pessac, France.
Blood Coagul Fibrinolysis. 1998 Sep;9(6):549-51. doi: 10.1097/00001721-199809000-00013.
We have developed a rapid method which allows us simultaneously to determine two genetic variations that are associated with an increased risk of venous thrombosis: the 20210 G-->A mutation present in the 3'-UT region of the prothrombin gene and the 1691 G-->A mutation giving rise to factor V Leiden. Our strategy involves the coamplification of exon 10 of the factor V gene and of the region 3' from the prothrombin gene using modified oligonucleotides, permitting the introduction of a single HindIII cleavage site in fragments bearing one of the mutations. As a result of its time- and cost-saving features, this combined method should be considered for screening large numbers of patients.
我们已经开发出一种快速方法,可让我们同时测定与静脉血栓形成风险增加相关的两种基因变异:凝血酶原基因3'-UT区域存在的20210 G→A突变以及导致因子V莱顿突变的1691 G→A突变。我们的策略包括使用修饰的寡核苷酸对因子V基因的第10外显子和凝血酶原基因3'区域进行共扩增,从而在携带其中一种突变的片段中引入单个HindIII切割位点。由于其节省时间和成本的特点,这种联合方法应用于筛查大量患者。